Dr. Luisa Sorlí Redó (Spain)
Dr. Luisa Sorlí worked as an Infectious Diseases Physician at the Hospital del Mar in Barcelona.
At this time, Dr. Luisa Sorlí is working in the Post-Surgical Medical Care Unit and Hematologist Service as a consultant. The treatment of multidrug-resistant Gram-negative bacilli infections and the pharmacokinetics and pharmacodynamics of antibiotics, including colistin, are of interest to her.
In addition, Dr. Luisa Sorlí hold a position on a research team. Their research group has dedicated the majority of its focus to investigating the clinical pharmacokinetics of colistin (CMS). The results obtained from their research have significantly influenced the field of clinical practice.
At present, their research also encompasses the examination of the pharmacokinetics of newly developed antibiotics (beta-lactams in combination with beta-lactamase inhibitors) in plasma and the epithelial lung fluid.
Dr. Luisa Sorlí worked as an Infectious Diseases Physician at the Hospital del Mar in Barcelona.
At this time, Dr. Luisa Sorlí is working in the Post-Surgical Medical Care Unit and Hematologist Service as a consultant. The treatment of multidrug-resistant Gram-negative bacilli infections and the pharmacokinetics and pharmacodynamics of antibiotics, including colistin, are of interest to her.
In addition, Dr. Luisa Sorlí hold a position on a research team. Their research group has dedicated the majority of its focus to investigating the clinical pharmacokinetics of colistin (CMS). The results obtained from their research have significantly influenced the field of clinical practice.
At present, their research also encompasses the examination of the pharmacokinetics of newly developed antibiotics (beta-lactams in combination with beta-lactamase inhibitors) in plasma and the epithelial lung fluid.